Technology | September 26, 2011

Infinitt Xelis Image Fusion Software Receives FDA Clearance

September 26, 2011 Infinitt North America said its Xelis Fusion software has received clearance from the U.S. Food and Drug Administration (FDA), and is now widely available to the North American market.  

The software can be used as an integrated solution with the company’s web-based picture archiving and communication system (PACS) or as a stand-alone solution; this allows any third-party PACS user to query, view and analyze studies from any DICOM database to do fusion of computed tomography (CT), positron emission tomography (PET) and magnetic resonance (MR) images. 

According to the company, the system has been in use at 12 institutions across the United States and has demonstrated the ability to improve diagnosis and enhance productivity.

The Xelis Fusion:

- Supports fusion of PET, CT and MR data in any combination

- Offers automatic and manual registration methods, quantitative analysis tools and rapid image navigation

- Supports 3-D region of interest (ROI) analysis

- Provides presets and layouts for comparing two image sets

- Calculates PET Standard Uptake Values (SUV)

- Offers multiple standard and user-defined color maps

- Stores/sends the fused images in DICOM 3.0 format

- Includes integrated, freely rotating MPR functions

PET/CT fusion is used primarily to assist in more accurate and reliable diagnosis of cancer, and is covered by most private insurance companies and Medicare. Co-registration and alignment of different scans showing the same patient and pathology can add value to numerous image-based clinical review processes.

Medicare is continually adding to its list of approved clinical indications for PET and PET-CT. Currently Medicare reimburses for PET and PET-CT for:

- Single pulmonary nodules

- Non small cell lung cancer

- Colorectal cancer

- Melanoma

- Lymphoma

- Head and neck cancer (excluding CNS and thyroid cancers)

- Esophageal cancer

- Breast cancer

- Cervical cancer

For more information: www.infinittna.com


 

Related Content

National Clinical Decision Support Company (NDSC) has an exclusive deal with the American College of Radiology (ACR) to provide medical imaging appropriate use criteria (AUC).

National Clinical Decision Support Company (NDSC) has an exclusive deal with the American College of Radiology (ACR) to provide medical imaging appropriate use criteria (AUC). 

Feature | Clinical Decision Support | January 18, 2018
January 18, 2018 — Change Healthcare announced the acquisition of National Decision Support Company (NDSC), a leader
Hospital for Special Surgery Invests in Sectra Orthopedic 3-D Planning Software
News | Orthopedic Imaging | January 18, 2018
January 18, 2018 – International medical imaging IT and cybersecurity company Sectra announces that Hospital for Spec
Videos | Artificial Intelligence | January 18, 2018
ITN Contributing Editor Greg Freiherr offers an overview of artificial intelligence advances at the Radiological Soci
Philips Introduces Technology Maximizer Program for Imaging Equipment Upgrades
Technology | Imaging | January 17, 2018
January 17, 2018 — Philips recently announced the launch of Technology Maximizer, a cross-modality program designed t
Sponsored Content | Videos | Enterprise Imaging | January 17, 2018
Mitchell Goldburgh, global solutions manager for enterprise imaging and analytics manager for NTT Data Services, form
Sponsored Content | Videos | Enterprise Imaging | January 16, 2018
Built on an over 25-year pioneering legacy in the advanced visualization industry, Vital continues to expand on three
RSNA 2017 Celebrates Innovation in Radiology
News | Imaging | January 15, 2018
January 15, 2018 — The Radiological Society of North America’s...
News | Clinical Decision Support | January 12, 2018
January 12, 2018 — GE Healthcare has entered into a strategic, long-term partnership with Roche to jointly develop an
The artificial intelligence (AI) smart algorithm onboard the Infervision stroke product calculates the volume of bleed on the basis of multiple brain CT slices.

The AI smart algorithm onboard the Infervision stroke product calculates the volume of bleed on the basis of multiple brain CT slices. The size of the bleed volume indicates the urgency and type of treatment required.

Feature | Artificial Intelligence | January 10, 2018 | Greg Freiherr
Exhibitors at the 2017 Radiological Society of North American (RSNA) meeting rode the...
Videos | Enterprise Imaging | January 09, 2018
Konica Minolta President of Healthcare IT Steve Deaton details new features in the Exa Platform designed to improve c
Overlay Init